Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)

Name: Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)
Published: 2018
License: Public Domain

Merck KGaA, Darmstadt, Germany · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

multiple sclerosis, mavenclad®, cladribine, health-related quality of life, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)

Related documents